Zymeworks Quarterly Balance Sheet
NASDAQ: ZYMEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Zymeworks financial position
As of Jun 30, 2026, Zymeworks reported total assets of $397.0 million, down 2.8% from a year earlier against total liabilities of $316.6 million. Shareholders' equity stood at $80.4 million, or 20.2% of assets. The company held $179.4 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 6.32, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Zymeworks balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 179.41M | 244.28M | 41.16M | 64.83M | 98.25M | 76.20M | 66.10M | 122.36M | 70.96M | 114.81M | 157.56M | 94.33M |
| Short-Term Investments | — | — | — | — | — | — | — | — | — | — | 216.77M | 201.07M |
| Receivables | 5.93M | 4.67M | 4.64M | 29.35M | 2.63M | 24.59M | 55.81M | 23.70M | 32.08M | 30.95M | 19.48M | 67.27M |
| Total Current Assets | 298.39M | 385.68M | 248.77M | 291.71M | 296.13M | 306.47M | 300.45M | 343.77M | 383.50M | 393.82M | 412.93M | 374.63M |
| Property, Plant & Equipment | 13.96M | 14.85M | 15.50M | 15.82M | 16.31M | 16.68M | 17.65M | 18.33M | 18.47M | 18.97M | 19.85M | 20.90M |
| Goodwill | 12.02M | 12.02M | 12.02M | 12.02M | 12.02M | 12.02M | 12.02M | 12.02M | 12.02M | 12.02M | 12.02M | 12.02M |
| Intangible Assets | 998.00K | 1.17M | 1.35M | 1.40M | 2.04M | 3.36M | 4.58M | 6.41M | 7.11M | 7.42M | 7.66M | 8.00M |
| Long-Term Investments | — | — | — | — | — | — | — | — | — | — | 82.15M | 95.67M |
| Total Assets | 396.96M | 478.21M | 346.53M | 397.27M | 408.38M | 425.52M | 463.09M | 487.15M | 515.63M | 553.75M | 580.88M | 556.37M |
| Accounts Payable | 27.46M | 30.23M | 4.40M | 1.30M | 32.00K | 5.22M | 3.90M | 3.42M | 1.73M | 2.52M | 6.21M | 11.01M |
| Total Current Liabilities | 47.24M | 35.65M | 42.32M | 42.04M | 38.50M | 65.10M | 88.29M | 83.91M | 54.71M | 56.89M | 55.76M | 72.85M |
| Total Liabilities | 316.60M | 314.63M | 78.03M | 77.20M | 73.88M | 100.56M | 124.32M | 120.17M | 109.47M | 115.75M | 116.07M | 132.02M |
| Shareholders' Equity | 80.37M | 163.59M | 268.50M | 320.06M | 334.51M | 324.97M | 338.77M | 366.98M | 406.16M | 438.00M | 464.81M | 424.34M |
| Retained Earnings | -1.17B | -1.07B | -953.16M | -886.47M | -850.65M | -852.97M | -830.34M | -797.83M | -746.78M | -709.09M | -677.44M | -662.96M |
| Net Cash (Debt) | 179.41M | 244.28M | 41.16M | 64.83M | 98.25M | 76.20M | 66.10M | 122.36M | 70.96M | 114.81M | 374.33M | 295.41M |
| Shares Outstanding | 71.41M | 73.10M | 74.64M | 75.14M | 74.85M | 69.58M | 68.96M | 69.58M | 70.83M | 70.68M | 70.12M | 67.92M |
This table shows 12 quarterly periods of Zymeworks's balance sheet, from Q2 2026 back to Q3 2023, across 16 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow ZYME's reporting calendar. What is a balance sheet?